Xcout IntelTolvac Therapeutics
Tolvac Therapeutics is a company that develops a novel type of treatment for autoimmune diseases. The company signed an exclusive license agreement with Utrecht.
The full profile of Tolvac Therapeutics
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Tolvac Therapeutics →Already a subscriber? Sign in
Xcout Intel tracks Tolvac Therapeutics continuously — this profile deepens as new filings, funding, people and hiring data arrive.